Balyasny Asset Management
MDWD icon

Balyasny Asset Management’s MediWound MDWD Stock Holding History

Balyasny Asset Management’s Portfolio MDWD Stock Details MDWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,147
Closed -$704K – 3260
2025
Q4 		$704K Sell
38,147
-38,147
-50% -$697K ﹤0.01% 2357
2025
Q3 		$1.37M Buy
76,294
+742
+1% +$13.7K ﹤0.01% 1988
2025
Q2 		$1.46M Sell
75,552
-30,038
-28% -$566K ﹤0.01% 1888
2025
Q1 		$1.64M Sell
105,590
-60,141
-36% -$1.08M ﹤0.01% 1795
2024
Q4 		$2.95M Sell
165,731
-5
-0% -$86 ﹤0.01% 1518
2024
Q3 		$2.99M Buy
165,736
+13,401
+9% +$245K ﹤0.01% 1495
2024
Q2 		$2.36M Buy
152,335
+89,804
+144% +$1.48M ﹤0.01% 1470
2024
Q1 		$891K Buy
+62,531
New +$856K ﹤0.01% 1837

Other funds holding MDWD

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
YLHM
Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management's MDWD Position: Q1 2026 in Review

Balyasny Asset Management sold out of MediWound (MDWD) in Q1 2026, closing a stake of 38,147 shares — an estimated $704K sold.

Balyasny Asset Management first reported a position in MDWD in Q1 2024 and held it in 8 quarters. The position peaked at $2.99M in Q3 2024. 76 funds tracked by Wall St. Rank hold MDWD as of Q1 2026.

  • Balyasny Asset Management reported no remaining MediWound position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 38,147 MediWound shares in Q1 2026, an estimated $704K.
  • Balyasny Asset Management first reported a position in MediWound in Q1 2024 and held it in 8 quarters.
  • Balyasny Asset Management's MediWound position peaked at $2.99M in Q3 2024.
  • 76 funds tracked by Wall St. Rank held MediWound as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.